Intermediates useful for synthesis of heteroaryl-substituted...

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S237000, C544S238000, C544S333000, C544S353000, C544S257000, C544S284000, C544S405000, C544S264000, C544S140000, C544S371000, C546S167000, C546S144000, C546S211000, C546S275400, C548S215000, C548S217000, C548S240000, C548S241000, C548S255000, C548S266200, C548S306100, C548S314700, C548S364700, C548S364100, C548S364400, C548S371400

Reexamination Certificate

active

06894173

ABSTRACT:
Disclosed are novel processes and novel intermediate compounds for preparing aryl-and heteroaryl-substituted urea compounds of the formula(I) wherein Ar1, Ar2, L, Q and X are described herein. The product compounds are useful in pharmaceutic compositions for treating diseases or pathological conditions involving inflammation such as chronic inflammatory diseases.

REFERENCES:
patent: 3291808 (1966-12-01), Elslager et al.
patent: 4105766 (1978-08-01), Alexander
patent: 4447624 (1984-05-01), Krutak et al.
patent: 5162360 (1992-11-01), Creswell et al.
patent: 5686455 (1997-11-01), Adams et al.
patent: 5739143 (1998-04-01), Adams et al.
patent: 5777097 (1998-07-01), Lee et al.
patent: 5783664 (1998-07-01), Lee et al.
patent: 5859041 (1999-01-01), Liverton et al.
patent: 5869043 (1999-02-01), McDonnell et al.
patent: 5871934 (1999-02-01), Lee et al.
patent: 5916760 (1999-06-01), Goeddel et al.
patent: 5948885 (1999-09-01), Stein et al.
patent: 6242453 (2001-06-01), Cirillo et al.
patent: 6297381 (2001-10-01), Cirillo et al.
patent: 6358945 (2002-03-01), Breitfelder et al.
patent: 293 352 (1991-08-01), None
patent: 61228444 (1986-10-01), None
patent: 0 272 866 (1988-06-01), None
patent: 0692483 (1996-01-01), None
patent: 0859054 (1998-08-01), None
patent: 0922762 (1999-06-01), None
patent: WO 9422866 (1994-10-01), None
patent: WO 9625157 (1996-08-01), None
patent: WO 9640143 (1996-12-01), None
patent: WO 9722704 (1997-06-01), None
patent: WO 9733883 (1997-09-01), None
patent: WO 9735855 (1997-10-01), None
patent: WO 9735856 (1997-10-01), None
patent: WO 9744467 (1997-11-01), None
patent: WO 9747618 (1997-12-01), None
patent: WO 9748697 (1997-12-01), None
patent: WO 9807425 (1998-02-01), None
patent: WO 9815618 (1998-04-01), None
patent: WO 9827098 (1998-06-01), None
patent: WO 9852558 (1998-11-01), None
patent: WO 9852559 (1998-11-01), None
patent: WO 9900357 (1999-01-01), None
patent: WO 9932106 (1999-07-01), None
patent: WO 9932110 (1999-07-01), None
patent: WO 9932111 (1999-07-01), None
patent: WO 9932455 (1999-07-01), None
patent: WO 9932463 (1999-07-01), None
patent: WO 9946244 (1999-09-01), None
patent: WO 0043384 (2000-07-01), None
International Search Report, Boehringer Ingelheim Pharmaceuticals, Inc., Apr. 12, 2000.
Jeffrey C. Boehm & Jerry L. Adams, New inhibitors of p38 kinase, Expert Opin.Ther. Patents (2000) 10(1):25-37.
Two novel structural classes of P38 kinase inhibitors; Exp. Opin. Ther. Patents (1999) 9(4) 477-480.
SB 203580, Calbiochem—Cat. No. 559389—Revised May 30, 1997.
Jagadish C. Sircar, et al; Pyrazolo[5,1-b] quinazolin-9 ones: A New Series of Antiallergic Agents, J. Med. Chem. 1981, 24, 735-742.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Intermediates useful for synthesis of heteroaryl-substituted... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intermediates useful for synthesis of heteroaryl-substituted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intermediates useful for synthesis of heteroaryl-substituted... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3405078

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.